Anxiety Disorders in General Medical Practice

Dzyak, Liudmyla; Tsurakalenko, Olena

doi:10.30841/2307-5112.5.2016.248670

FMEP

2016

DOI: 10.30841/2307-5112.5.2016.248670

|View full text |Cite

Anxiety Disorders in General Medical Practice

Liudmyla Dzyak

Olena Tsurakalenko

Abstract: Timely diagnosis and early initiation of adequate therapy of disorders of the alarming spectrum (AS) remains one of the urgent tasks of modern medicine. The article considers aspects of diagnosis and treatment of AS in General medical network, particularly were described the currently recommended schemes of application of the drug Eglonil and benefits of this drug. Eglonil demonstrates the possibility of wide application of different variants of anxiety disorders, which gives the drug a special status am… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Pharmacotherapy of Anxiety Syndrome in Psychosomatic Pathology: Drug Selection Criteria

Serhii

Nataliya

Viktor

2022

FMEP

View full text Add to dashboard Cite

The article examines modern approaches to the problem of psychoemotional disorders and, in particular, anxiety syndrome in psychosomatic pathology. Special attention is paid to the somatic «masks» of the anxiety syndrome in the most common clinical forms of psychosomatics, as well as the role of chronic stress in the pathogenesis of the specified syndrome and in the occurrence of neurotransmitter imbalance, which is the basis of the development of anxiety disorders. The advantages and disadvantages of the main groups of drugs used to treat anxiety in patients with various nosological forms of psychosomatic pathology are analyzed. In this regard, special attention is paid to the possibilities of combined phytotherapeutic agents. The advantages of the combination within one dosage form of plant components with proven synergistic anxiolytic action are emphasized. This combination is the original domestic phytotherapeutic agent, which for the first time contains a combination of Vitania extract, L-theanine and Passiflora extract. The peculiarities of the mechanisms of action of each of the components of the specified combination and the justification of the expediency of their combination from the point of view of the impact on the main pathogenetic mechanisms of the development of the anxiety syndrome are considered. Special attention is paid to the issue of safety during therapy with the specified agent as one of the leading criteria for choosing a tool for the treatment of psycho-emotional disorders in psychosomatic pathology. Reasoned expediency of using the considered phytotherapeutic combination in the treatment of various clinical forms of anxiety disorders in general medical practice.

show abstract

Pharmacotherapy of Anxiety Syndrome in Psychosomatic Pathology: Drug Selection Criteria

Serhii

Nataliya

Viktor

2022

FMEP

View full text Add to dashboard Cite

show abstract

Anxiety disorders in neurology practice

Kolomytsev,

Goryunova,

Skvortsov

2023

Bulletin of Neurology, Psychiatry and Neurosurgery

View full text Add to dashboard Cite

Anxiety disorders are often encountered in the practice of a neurologist. These disorders are in various relationships with a neurological disease, based on which three groups of pathologies can be distinguished: anxiety disorders, manifested by somatic neurological symptoms arising from dysfunction the autonomic nervous system; anxiety disorders associated with major neurological diseases, such as epilepsy, migraine, and stroke; anxiety disorders resulting from side effects of therapy for the underlying somatic disease, including neurological one. In the first case, a neurologist must differentiate an anxiety disorder from a true nervous pathology, which is necessary in order to prescribe the correct therapy. In the second case, it is the responsibility of a neurologist to differentiate the symptoms of an anxiety disorder that occurs against the background of an underlying neurological disease from a progressive disease of the nervous system and prescribe specific therapy for a comorbid anxiety disorder. In the third case, a neurologist should take a detailed patient’s history to identify the relationship between the onset/intensification of manifestations and therapy. To assess the level of anxiety and its dynamics, it is necessary to use psychometric scales and symptomatic questionnaires. Therapy of anxiety disorders includes two areas: psychotherapy and psychopharmacotherapy; in order to achieve the maximum effect in severe cases of anxiety disorders, it is possible to combine these components. The preferred method of psychotherapy is cognitive behavioral therapy. Psychopharmacotherapy is represented by two lines. The first-line includes drugs from the group of selective serotonin reuptake inhibitors, while the second-line therapy involves increasing the dose of the drug or changing to serotonin and norepinephrine reuptake inhibitors.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Anxiety Disorders in General Medical Practice

Cited by 2 publications

References 4 publications

Pharmacotherapy of Anxiety Syndrome in Psychosomatic Pathology: Drug Selection Criteria

Pharmacotherapy of Anxiety Syndrome in Psychosomatic Pathology: Drug Selection Criteria

Anxiety disorders in neurology practice

Contact Info

Product

Resources

About